Healthtech CEO Forum

Healthtech CEO Forum

Tuesday, June 21 9:15am - 10:45am

Agenda | Hosts | Book

Open to CEO, Founder, Co-Founder, President, Chairman or c-suite executive (CFO, CBO, CCO, CSO, CMO) of a US-based Healthtech and digital health company.

Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants. 

  • Benchmark yourself against your peers
  • Uncover key factors of success
  • Share war stories and common challenges
  • Engage in peer-to-peer discussion
  • Make meaningful connections
  • Find new ways to help your business thrive


There’s nothing that comes close to hearing the honest advice and experience of peers treading the same path as you. LSX’s CEO Forums offer executives the chance to exchange ideas with and seek advice from peers in a private group setting. They are an opportunity to share learnings, best practice and some great thinking, as well as meeting other influential people to support your business journey. Capped at 20 participants, the forums operate under strict Chatham House Rule.

09:15am Opening remarks and introductions

Moderator: Morrison & Foerster LLP

09:20am Case study TBD

Matthew Karlyn, Partner, Morrison & Foerster LLP

Matthew Karlyn, Partner, Morrison & Foerster LLP

09:35am Q&A

09:45am From DTC Wellness to Precision Care Digital Therapy

  • Investor appetite in point solutions vs. Precision Care total solutions
  • Challenges in expanding globally with Precision Care total solutions
  • The need for multiple business models to monetize Precision Care total solutions

Chris Wasden, Chief Strategy Officer, Happify Health

Chris Wasden, Head, Happify Health

10:00am Healthtech CEO case study TBD

10:15am Group discussion

10:45am General Discussion (suggested topics to include but not limited to)

  • Fundraising challenges and opportunities
  • Overcoming barriers to market and regulatory approval
  • Creating the right deals and partnerships to move your business forward
  • Internationalising and company growth


Morrison & Foerster